Aptagen, LLC
S. Enterica Serovar Typhi IVP Pili Protein (S-PS8.4) (ID# 7532)
![](https://www.aptagen.com/wp-content/uploads/Typhi-IVP-pili-protein.png)
RNA
S. Enterica Serovar Typhi IVP Pili Protein
Protein
7.2 nM (reported value)
Binding Buffer (25 mM Tris-HCl, 50 mM KCl, 200 mM NaCl, 0.2 mM EDTA, 5% [vol/vol] glycerol, 0.5 mM DTT)
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-rGprGprGprAprAprCprAprGprUprCprCprGprAprGprCprCprUprCprAprCprUprGprUprUprAprUprCprCprGprAprUprAprGprCprAprGprCprGprCprGprGprGprAprUprGprAprGprGprGprUprCprAprAprUprGprCprGprUprCprAprUprAprGprGprAprUprCprCprCprGprCp-3'
![](/wp-content/uploads/apta-sequence-abbr.png)
71
22923.86
696500
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Pan, Q., et al. "Aptamers That Preferentially Bind Type IVB Pili and Inhibit Human Monocytic-Cell Invasion by Salmonella enterica Serovar Typhi." Antimicrobial Agents and Chemotherapy, 49(2005): 4052-4060.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.